Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James F. List
Observed names:
J F List,
J List,
J. F. List,
J. List,
J.F. List,
James F List,
James List
show all 7
Institution:
Janssen Research & Development (United States)
Observed institutions:
Howard Hughes Medical Institute,
Harvard University,
Princeton University,
Massachusetts General Hospital,
Bristol-Myers Squibb (United States),
Janssen Research & Development (United States)
show all 6
OpenAlex ID:
A5111609755
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
2010
·
Clifford J Bailey
, Jorge L Gross
, et al.
·
The Lancet
·
861
Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes
2013
·
H. J. Lambers Heerspink
, D. de Zeeuw
, et al.
·
Diabetes Obesity and Metabolism
·
837
PDF
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise
2010
·
Ele Ferrannini
, Silvia Jimenez Ramos
, et al.
·
Diabetes Care
·
719
PDF
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
2008
·
James F. List
, Vincent Woo
, et al.
·
Diabetes Care
·
692
PDF
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
2013
·
Donald E. Kohan
, Paola Fioretto
, et al.
·
Kidney International
·
649
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
2012
·
Julio Rosenstock
, Marisa Vico
, et al.
·
Diabetes Care
·
409
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers
2009
·
John P.H. Wilding
, Paul Norwood
, et al.
·
Diabetes Care
·
362
PDF
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
2013
·
Clifford J Bailey
, Jorge L Gross
, et al.
·
BMC Medicine
·
354
PDF
Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
2012
·
R. R. Henry
, A. V. Murray
, et al.
·
International Journal of Clinical Practice
·
312
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
2009
·
J. Rosenstock
, C. Aguilar-Salinas
, et al.
·
Current Medical Research and Opinion
·
285
Genital and urinary tract infections in diabetes: Impact of pharmacologically-induced glucosuria
2014
·
Suzanne Geerlings
, Vivian Fonseca
, et al.
·
Diabetes Research and Clinical Practice
·
278
PDF
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
2018
·
W. Timothy Garvey
, Luc Van Gaal
, et al.
·
Metabolism
·
263
PDF
Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2014
·
Robert R. Henry
, Julio Rosenstock
, et al.
·
Diabetes Care
·
238
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
2009
·
A. R. Chacra
, G. H. Tan
, et al.
·
International Journal of Clinical Practice
·
236
Glucose‐lowering activity of the dipeptidyl peptidase‐4 inhibitor saxagliptin in drug‐naive patients with type 2 diabetes*
2008
·
J. Rosenstock
, S. Sankoh
, et al.
·
Diabetes Obesity and Metabolism
·
232
Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin
2013
·
Kristina M. Johnsson
, Agata Ptaszynska
, et al.
·
Journal of Diabetes and its Complications
·
212
Urinary tract infections in patients with diabetes treated with dapagliflozin
2013
·
Kristina M. Johnsson
, Agata Ptaszynska
, et al.
·
Journal of Diabetes and its Complications
·
205
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
2011
·
James F. List
, Jean M. Whaley
·
Kidney International
·
180
PDF
Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
2014
·
Linong Ji
, Jianhua Ma
, et al.
·
Clinical Therapeutics
·
171
PDF
Dapagliflozin monotherapy in drug‐naïve patients with diabetes: a randomized‐controlled trial of low‐dose range
2012
·
C. J. Bailey
, N. Iqbal
, et al.
·
Diabetes Obesity and Metabolism
·
169
Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight
2010
·
L. Zhang
, Y. Feng
, et al.
·
Diabetes Obesity and Metabolism
·
167
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
2004
·
Norihiko Ogawa
, James F. List
, et al.
·
Diabetes
·
154
Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial
2014
·
C. J. Bailey
, E. C. Morales Villegas
, et al.
·
Diabetic Medicine
·
153
Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events
2014
·
Agata Ptaszynska
, Kristina M. Johnsson
, et al.
·
Drug Safety
·
123
Effects of Dapagliflozin on Cardiovascular Risk Factors
2013
·
Agata Ptaszynska
, Elise Hardy
, et al.
·
Postgraduate Medicine
·
113
Show more works
View as search
Works count:
56
Citation count:
8,999
H-index:
32
I10-index:
35
Year
Topic
Type
